| Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics (NCT03711435) | Xuzhou Traditional Chinese Medicine Hospital | 2018-10-20 |
| Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis (NCT03499275) | Royal Brompton & Harefield NHS Foundation Trust | 2018-10-15 |
| A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT03725852) | Lakefront Biotherapeutics NV | 2018-09-27 |
| An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis (NCT03573505) | Biogen | 2018-09-24 |
| Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study (NCT03979430) | Heidelberg University | 2018-09-07 |
| University of Virginia Natural History Study (NCT04896138) | University of Virginia | 2018-08-28 |
| Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) (NCT03274544) | The University of Hong Kong | 2018-08-14 |
| Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) (NCT03562247) | Vanderbilt University Medical Center | 2018-08-01 |
| Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis (NCT03588260) | Istanbul Medipol University Hospital | 2018-07-20 |
| Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (NCT03567785) | KU Leuven | 2018-07-17 |
| Idiopathic Pulmonary Fibrosis Registry China Study (NCT03666234) | Dai Huaping | 2018-07-01 |
| Homecare Integral Support Program for IPF Patients (NCT05173571) | Institut d'Investigació Biomèdica de Bellvitge | 2018-07-01 |
| JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF (NCT03538301) | Nitto Denko Corporation | 2018-06-18 |
| Toward Self-management in ILD (NCT03300583) | Kingston University | 2018-06-01 |
| Acute Effects of Oxygen Supplementation Among IPF Patients (NCT03688334) | George Papanicolaou Hospital | 2018-06-01 |
| The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (NCT03502902) | Sunshine Lake Pharma Co., Ltd. | 2018-04-26 |
| Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure (NCT03500731) | Paul Szabolcs | 2018-04-19 |
| Detection of Early Idiopathic Pulmonary Fibrosis (NCT03457935) | Temple University | 2018-04-10 |
| Digital Auscultation Test - IPF Data Collection (NCT03503188) | Boehringer Ingelheim | 2018-03-28 |
| This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. (NCT03422068) | Boehringer Ingelheim | 2018-03-16 |
| Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis (NCT03411876) | Klaus Kenn | 2018-01-18 |
| Families-At-risk for Interstitial Lung Disease Study (NCT03641742) | Columbia University | 2018-01-15 |
| Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF (NCT03360032) | University Hospitals Coventry and Warwickshire NHS Trust | 2018-01-10 |
| Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life (NCT03420235) | Erasmus Medical Center | 2018-01-09 |
| PROOF-Registry New and Extended Belgium -Luxembourg (NCT03732859) | Belgian Thoracic Society | 2018-01-09 |
| A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) (NCT02871401) | Vanderbilt University Medical Center | 2018-01-03 |
| A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period (NCT03261037) | Hoffmann-La Roche | 2017-12-25 |
| Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis (NCT03287414) | Novartis Pharmaceuticals | 2017-12-20 |
| Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis. (NCT03229343) | Assistance Publique - Hôpitaux de Paris | 2017-12-04 |
| Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. (NCT03928847) | Hal Chapman | 2017-12-01 |
| Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT (NCT03183570) | Stanford University | 2017-11-08 |
| Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain (NCT03281200) | Boehringer Ingelheim | 2017-10-24 |
| Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). (NCT03208933) | Hoffmann-La Roche | 2017-10-23 |
| Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis (NCT03222648) | University Hospital Southampton NHS Foundation Trust | 2017-09-22 |
| Immunopathologic Profiles and Blood Biomarkers in Patients With IPF (NCT04187079) | University of Aarhus | 2017-09-18 |
| Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis (NCT03981406) | University of Minnesota | 2017-09-15 |
| Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis (NCT03480451) | Medical College of Wisconsin | 2017-09-12 |
| Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (NCT03548181) | University of Aarhus | 2017-09-01 |
| A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis (NCT03142191) | Celgene | 2017-07-26 |
| Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis (NCT03104322) | patientMpower Ltd. | 2017-06-15 |
| Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging (NCT03069989) | GlaxoSmithKline | 2017-06-13 |
| Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis (NCT03215147) | Seoul National University Hospital | 2017-06-07 |
| An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors (NCT05784207) | Maastricht University | 2017-06-01 |
| Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis (NCT03171870) | Assiut University | 2017-06-01 |
| The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects (NCT03092102) | Sunshine Lake Pharma Co., Ltd. | 2017-05-20 |
| Idiopathic Pulmonary Fibrosis Job Exposures Study (NCT03211507) | Imperial College London | 2017-05-01 |
| Quality of Life Study in Participants With IPF Under Pirfenidone Treatment (NCT03115619) | Hoffmann-La Roche | 2017-04-18 |
| Controls for Respiratory Diseases (NCT03120481) | Seoul National University Hospital | 2017-04-10 |
| Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis (NCT03047031) | Boehringer Ingelheim | 2017-04-05 |
| Investigating Idiopathic Pulmonary Fibrosis in Greece (NCT03074149) | Boehringer Ingelheim | 2017-04-04 |
| Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis (NCT02745184) | Shanghai East Hospital | 2017-03-30 |
| Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers (NCT02929017) | University of Pittsburgh | 2017-03-23 |
| CleanUP IPF for the Pulmonary Trials Cooperative (NCT02759120) | Weill Medical College of Cornell University | 2017-03-22 |
| Lung MRI in the Management of Idiopathic Pulmonary Fibrosis (NCT03078426) | University Hospital, Bordeaux | 2017-02-16 |
| Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test (NCT03268915) | University Hospital, Grenoble | 2017-02-09 |
| Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease (NCT04803617) | Habibedurdu | 2017-01-23 |
| Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease (NCT03560154) | Istanbul University | 2017-01-01 |
| Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension (NCT02951429) | Hoffmann-La Roche | 2016-12-31 |
| Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (NCT02989168) | Global Blood Therapeutics | 2016-11-01 |
| The Coagulation Cascade in Idiopathic Pulmonary Fibrosis (NCT02885961) | University College, London | 2016-08-01 |
| Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study (NCT05313672) | Roberto Tonelli | 2016-08-01 |
| Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up (NCT02818712) | Aarhus University Hospital | 2016-08-01 |
| Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment (NCT02802345) | Boehringer Ingelheim | 2016-06-30 |
| Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment (NCT02788474) | Boehringer Ingelheim | 2016-06-09 |
| Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study (NCT02821039) | Turkish Thoracic Society | 2016-06-01 |
| A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis (NCT02688647) | Kadmon Corporation, LLC | 2016-05-26 |
| Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis (NCT02739165) | Asahi Kasei Therapeutics Corporation | 2016-05-01 |
| Sleep Disorders in Idiopathic Pulmonary Fibrosis (NCT05113654) | Wissenschaftliches Institut Bethanien e.V | 2016-04-26 |
| A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination (NCT02606877) | Boehringer Ingelheim | 2016-04-19 |
| Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis (NCT02503657) | MediciNova | 2016-03-09 |
| Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay (NCT02772549) | Nils Hoyer | 2016-03-01 |
| Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT02738801) | Lakefront Biotherapeutics NV | 2016-03-01 |
| A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (NCT02648048) | Hoffmann-La Roche | 2016-01-15 |
| Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT02598193) | Hoffmann-La Roche | 2016-01-14 |
| Korean Idiopathic Pulmonary Fibrosis Registry (NCT04160715) | Seoul National University Hospital | 2016-01-01 |
| Exhaled Breath Condensate Biomarkers and Cough in IPF (NCT02630940) | University of East Anglia | 2016-01-01 |
| First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients (NCT02612051) | GlaxoSmithKline | 2015-12-04 |
| Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis (NCT02460588) | Assistance Publique - Hôpitaux de Paris | 2015-12-01 |
| Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis (NCT02632123) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-12-01 |
| High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib (NCT02551068) | University of British Columbia | 2015-12-01 |
| IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis (NCT02803580) | Boehringer Ingelheim | 2015-11-17 |
| Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF (NCT02579603) | Boehringer Ingelheim | 2015-10-16 |
| Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) (NCT02827734) | Universitätsmedizin Mannheim | 2015-10-01 |
| A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT02550873) | Hoffmann-La Roche | 2015-09-01 |
| A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) (NCT02502097) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-08-26 |
| Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis (NCT02600689) | University of Alabama at Birmingham | 2015-08-01 |
| A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT02477709) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-07-20 |
| Cromolyn Detection of Silent Aspiration (NCT01841307) | University of California, San Francisco | 2015-07-01 |
| Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis (NCT02187393) | University of Colorado, Denver | 2015-07-01 |
| Breath Analysis in Lung Fibrosis (NCT02437448) | University of Zurich | 2015-06-01 |
| The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease (NCT02019641) | National Institutes of Health Clinical Center (CC) | 2015-05-23 |
| PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort (NCT02407431) | University of Pittsburgh | 2015-03-01 |
| The Predictive Ability of 4MGS in IPF (NCT02436278) | Royal Brompton & Harefield NHS Foundation Trust | 2015-03-01 |
| Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects (NCT02397005) | Zai Lab Pty. Ltd. | 2015-03-01 |
| Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis (NCT02445157) | Royal Brompton & Harefield NHS Foundation Trust | 2015-02-01 |
| Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis (NCT02530736) | Royal Brompton & Harefield NHS Foundation Trust | 2015-02-01 |
| Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis (NCT02315586) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-01-28 |
| 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis (NCT02485886) | Peking Union Medical College Hospital | 2015-01-01 |
| Idiopathic Pulmonary Fibrosis and Serum Bank (NCT04016168) | Rennes University Hospital | 2014-10-22 |
| A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) (NCT02168530) | Hoffmann-La Roche | 2014-10-01 |